Top compounds associated with response to AL365202.1


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.05 0.1
mRNA ML320 CTRPv2 pan-cancer AAC 0.056 0.1
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.048 0.1
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.05 0.1
mRNA tosedostat CTRPv2 pan-cancer AAC 0.057 0.1
mRNA JW-480 CTRPv2 pan-cancer AAC 0.059 0.1
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.054 0.1
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.051 0.1
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.057 0.1
Download CSV